IP Biotech, Sinovac ink deal on flu vaccine

MANILA, Philippines – IP Biotech, an importer, wholesaler and retail administrator of high-quality, affordable vaccine treatments in the Philippines, and Sinovac Biotech Co. Ltd., a leading provider of vaccines in China, have announced an exclusive agreement for the distribution of Sinovac’s flu vaccine, Anflu, in the Philippines.

The Anflu vaccine utilizes the Southern Hemisphere virus strain recommended by the World Health Organization (WHO).

The partnership marks Sinovac’s entry into the Philippine market. Under the terms of the agreement, IP Biotech will distribute Anflu in the Philippine market nationwide, pending the completion of registration currently underway with the Bureau of Food and Drugs.

The vaccine will also be available through Family Vaccine and Specialty Clinics Inc., a chain of private vaccination clinics with over 30 facilities nationwide.